[ FDA ENFORCEMENT INTELLIGENCE ]
Learn from the record. Every FDA recall is a quality signal.
Live drug, device & food recall data from the FDA (openFDA enforcement) — food spanning dietary supplements, cosmetics & animal food — mapped to the GxP quality domains SPEQ assesses, so you can see where control breaks down across every regulated industry.
1,000
Total recalls
217
Class I (most serious)
167
Drug
515
Device
318
Food / supplement / cosmetic
Last 12 months · latest report 2026-07-22 · source: openFDA enforcement
RECALLS BY CLASSIFICATION · MONTHLY
RECALL REASONS BY QUALITY DOMAIN
Domain mapping is a SPEQ interpretation of the FDA recall reason, not an official FDA classification.
1,235 matching recalls
| Date | Class | Firm | Reason | Quality domain |
|---|---|---|---|---|
| 2026-06-17 | Class I | SUN PHARMACEUTICAL INDUSTRIES INCD-0580-2026 | Presence of Particulate matter: Particulate matter identified as glass. | Environmental Monitoring |
| 2026-06-17 | Class II | Avanos Medical, Inc.Z-2336-2026 | Lidocaine hydrochloride injection, the subject of a supplier recall for quality issues, were included into sterile kits and sets. | Environmental Monitoring |
| 2026-06-17 | Class I | Haleon US Holdings LLCD-0595-2026 | Chemical Contamination: contamination with a diluted propylene glycol-based coolant from a machine leakage during the packaging process. | Environmental Monitoring |
| 2026-06-17 | Class II | Avanos Medical, Inc.Z-2350-2026 | Lidocaine hydrochloride injection, the subject of a supplier recall for quality issues, were included into sterile kits and sets. | Environmental Monitoring |
| 2026-06-17 | Class II | Avanos Medical, Inc.Z-2347-2026 | Lidocaine hydrochloride injection, the subject of a supplier recall for quality issues, were included into sterile kits and sets. | Environmental Monitoring |
| 2026-06-17 | Class I | Total Nutrition IncH-0942-2026 | Product may be contaminated with Salmonella. | Environmental Monitoring |
| 2026-06-17 | Class II | Avanos Medical, Inc.Z-2349-2026 | Lidocaine hydrochloride injection, the subject of a supplier recall for quality issues, were included into sterile kits and sets. | Environmental Monitoring |
| 2026-06-17 | Class II | AVID Medical, Inc.Z-2407-2026 | Inadvertent distribution of sealed pouches that had not undergone validated sterilization. | Environmental Monitoring |
| 2026-06-17 | Class II | Avanos Medical, Inc.Z-2345-2026 | Lidocaine hydrochloride injection, the subject of a supplier recall for quality issues, were included into sterile kits and sets. | Environmental Monitoring |
| 2026-06-17 | Class II | Avanos Medical, Inc.Z-2333-2026 | Lidocaine hydrochloride injection, the subject of a supplier recall for quality issues, were included into sterile kits and sets. | Environmental Monitoring |
| 2026-06-17 | Class II | Zep IncD-0586-2026 | Microbial contamination of sterile products | Environmental Monitoring |
| 2026-06-17 | Class II | Boston Scientific Neuromodulation CorporationZ-2404-2026 | Sterile anchors my lack sterility assurance. | Environmental Monitoring |
| 2026-06-17 | Class II | Avanos Medical, Inc.Z-2338-2026 | Lidocaine hydrochloride injection, the subject of a supplier recall for quality issues, were included into sterile kits and sets. | Environmental Monitoring |
| 2026-06-17 | Class I | BEEKEEPER'S NATURALS USA INC.D-0620-2026 | Microbial Contamination of Non-Sterile Products | Environmental Monitoring |
| 2026-06-17 | Class II | Avanos Medical, Inc.Z-2348-2026 | Lidocaine hydrochloride injection, the subject of a supplier recall for quality issues, were included into sterile kits and sets. | Environmental Monitoring |
| 2026-06-17 | Class II | Avanos Medical, Inc.Z-2346-2026 | Lidocaine hydrochloride injection, the subject of a supplier recall for quality issues, were included into sterile kits and sets. | Environmental Monitoring |
| 2026-06-17 | Class II | Avanos Medical, Inc.Z-2335-2026 | Lidocaine hydrochloride injection, the subject of a supplier recall for quality issues, were included into sterile kits and sets. | Environmental Monitoring |
| 2026-06-17 | Class II | Avanos Medical, Inc.Z-2339-2026 | Lidocaine hydrochloride injection, the subject of a supplier recall for quality issues, were included into sterile kits and sets. | Environmental Monitoring |
| 2026-06-17 | Class II | Avanos Medical, Inc.Z-2340-2026 | Lidocaine hydrochloride injection, the subject of a supplier recall for quality issues, were included into sterile kits and sets. | Environmental Monitoring |
| 2026-06-17 | Class II | Avanos Medical, Inc.Z-2343-2026 | Lidocaine hydrochloride injection, the subject of a supplier recall for quality issues, were included into sterile kits and sets. | Environmental Monitoring |
| 2026-06-17 | Class II | Avanos Medical, Inc.Z-2334-2026 | Lidocaine hydrochloride injection, the subject of a supplier recall for quality issues, were included into sterile kits and sets. | Environmental Monitoring |
| 2026-06-17 | Class II | Avanos Medical, Inc.Z-2351-2026 | Lidocaine hydrochloride injection, the subject of a supplier recall for quality issues, were included into sterile kits and sets. | Environmental Monitoring |
| 2026-06-17 | Class II | Avanos Medical, Inc.Z-2337-2026 | Lidocaine hydrochloride injection, the subject of a supplier recall for quality issues, were included into sterile kits and sets. | Environmental Monitoring |
| 2026-06-17 | Class II | Avanos Medical, Inc.Z-2352-2026 | Lidocaine hydrochloride injection, the subject of a supplier recall for quality issues, were included into sterile kits and sets. | Environmental Monitoring |
| 2026-06-17 | Class II | Avanos Medical, Inc.Z-2342-2026 | Lidocaine hydrochloride injection, the subject of a supplier recall for quality issues, were included into sterile kits and sets. | Environmental Monitoring |
Data: U.S. FDA openFDA enforcement API. Quality-domain mapping and severity are a SPEQ editorial interpretation of the recall reason, not an official FDA classification. Recall details are as reported by the FDA.